Response to anakinra in new-onset refractory status epilepticus: A clinical case
Seizure
.
2022 Jan:94:92-94.
doi: 10.1016/j.seizure.2021.11.014.
Epub 2021 Dec 4.
Authors
Michael Palacios-Mendoza
1
,
Ana Gómez
2
,
Julio Prieto
3
,
Juan Camilo Barrios
4
,
María Orera
5
,
Andreu Massot-Tarrús
6
Affiliations
1
Department of Neurology, Hospital General Universitario Gregorio Marañón, Madrid, Spain. Electronic address: michaelpalmend@gmail.com.
2
Department of Neurology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
3
Department of Neurophysiology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
4
Intensive Care Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
5
Unit of Genetics, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
6
Department of Neurology, F. Ass. Mútua Terrassa, Terrassa, Spain.
PMID:
34875544
DOI:
10.1016/j.seizure.2021.11.014
No abstract available
Keywords:
Anakinra; Interleukin-1; New-onset refractory status epilepticus; Status epilepticus.